Antimicrobial peptides: Therapeutic potential as an alternative to conventional antibiotics
DOI:
https://doi.org/10.56511/JIPBS.2017.v4.i01.pp25-32Abstract
Antibiotics are among the most important class of therapeutics to treat life threatening diseases, however, the emergence of multi-drug resistance bacteria is a serious threat to public health. Since conventional antibiotics are becoming resistant to all approved antimicrobial drugs, there is an urgent need to find alternative therapeutic agents. Antimicrobial peptides (AMPs) are naturally occurring host peptides produced by various organisms, as part of the non-specific immune response to defend against microbes. They have received great attention serving as a new class of antimicrobial agents, to counter multidrug resistance because of their broad spectrum activities against microorganism and low propensity to develop resistance. By focusing on developing optimized peptide designs using computer assisted approaches and applying advanced bioinformatic tools to consider factors such as peptides physical stability in physiological condition, and reduced toxicity to host cells, AMP can fulfill in the future as promising next generation antibiotics to fight drug resistant bacteria.
Keywords:
Antimicrobial peptides, antimicrobial resistance, antibiotics, host defense peptide, drug resistant bacteria, alternative antibiotic drug development, synthetic antimicrobial peptideDownloads
References
Zasloff M: Antimicrobial peptides of multicellular organisms. Nature 2002; 415:89-95
Demain AL, Sanchez S: Microbial drug discovery: 80 years of progress. The Journal of antibiotics 2009; 62:5-16.
Jenssen H, Hamill P, Hancock RE: Peptide antimicrobial agents. Clinical microbiology reviews 2006; 19:491-511.
Kaufmann BB, Hung DT: The fast track to multidrug resistance. Molecular cell 2010; 37:297-8.
Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y: Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrobial agents and chemotherapy 2006; 50:43-8.
Manchanda V, Sanchaita S, Singh NP: Multidrug resistant acinetobacter. Journal of global infectious diseases 2010; 2:291.
Baltzer SA, Brown MH: Antimicrobial peptides – promising alternatives to conventional antibiotics. Journal of molecular microbiology and biotechnology 2011; 20:228-35.
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H: Linezolid for treatment of chronic extensively drug-resistant tuberculosis. New England Journal of Medicine 2012; 367:1508-1518.
García MS, De la Torre MÁ, Morales G, Peláez B, Tolón MJ, Domingo S, Candel FJ, Andrade R, Arribi A, García N, Sagasti FM: Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010; 303:2260-2264.
Wang S, Zeng X, Yang Q, Qiao S: Antimicrobial peptides as potential alternatives to antibiotics in food animal industry. International journal of molecular sciences 2016; 17:603.
Alanis AJ: Resistance to antibiotics: Are we in the post-antibiotic era?. Archives of medical research 2005; 36:697-705.
Cooper MA, Shlaes D: Fix the antibiotics pipeline. Nature 2011; 472:32.
Brown KL, Mookherjee N, Hancock RE. Antimicrobial, host defence peptides and proteins. Encyclopedia of Life Sciences. Chichester, Wiley, 2007; 1 – 11.
Hancock RE. Cationic peptides: effectors in innate immunity and novel antimicrobials. The Lancet infectious diseases. 2001; 1:156-64.
Andreu D, Rivas L: Animal antimicrobial peptides: an overview. Peptide Science 1998; 47:415-33.
Bradshaw JP: Cationic antimicrobial peptides. BioDrugs 2003; 17:233-40.
Parachin NS, Franco OL: New edge of antibiotic development: antimicrobial peptides and corresponding resistance. Frontiers in microbiology 2014; 5.
Fox JL: Antimicrobial peptides stage a comeback. Nature biotechnology 2013; 31:379.
Hancock RE, Scott MG: The role of antimicrobial peptides in animal defenses. Proc Nat Acad Sci. 2000; 97:8856-61.
Brown KL, Hancock RE: Cationic host defense (antimicrobial) peptides. Current opinion in immunology 2006; 18:24-30.
Zeya HI, Spitznagel JK: Cationic proteins of polymorphonuclear leukocyte lysosomes II. Composition, properties, and mechanism of antibacterial action. Journal of bacteriology 1966; 91:755-62.
Boman HG: Antibacterial peptides: basic facts and emerging concepts. Journal of internal medicine 2003; 254:197-215.
Zasloff M: Antibiotic peptides as mediators of innate immunity. Current opinion in immunology 1992; 4:3-7.
Hoskin DW, Ramamoorthy A: Studies on anticancer activities of antimicrobial peptides. Biochimica et Biophysica Acta (BBA)- Biomembranes 2008; 1778:357-75.
Chung YS, Kocks C: Recognition of pathogenic microbes by the Drosophila phagocytic pattern recognition receptor Eater. Journal of Biological Chemistry 2011; 286:26524-32.
Alalwani SM, Sierigk J, Herr C, Pinkenburg O, Gallo R, Vogelmeier C, Bals R: The antimicrobial peptide LL ‐ 37 modulates the inflammatory and host defense response of human neutrophils. European journal of immunology 2010; 40:1118-26.
Van der Does AM, Bogaards SJ, Ravensbergen B, Beekhuizen H, van Dissel JT, Nibbering PH: Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens. Antimicrobial agents and chemotherapy 2010; 54 :811-6.
Shai Y: Mode of action of membrane active antimicrobial peptides. Peptide Science 2002; 66:236-48.
Dawson RM, Liu CQ: Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Critical reviews in microbiology 2008; 34:89-107.
Hancock RE, Lehrer R: Cationic peptides: a new source of antibiotics. Trends in biotechnology 1998; 16:82-8.
Straus SK, Hancock RE: Mode of action of the new antibiotic for Grampositive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochimica et Biophysica Acta (BBA)- Biomembranes 2006; 1758:1215-23.
Appelt C, Schrey AK, Söderhäll JA, Schmieder P: Design of antimicrobial compounds based on peptide structures. Bioorganic & medicinal chemistry letters 2007; 17:2334-7.
Keymanesh K, Soltani S, Sardari S: Application of antimicrobial peptides in agriculture and food industry. World Journal of Microbiology and Biotechnology 2009; 25:933-44.
Giuliani A, Pirri G, Nicoletto S: Antimicrobial peptides: an overview of a promising class of therapeutics. Open Life Sciences 2007; 2:1-33.
Fjell CD, Hiss JA, Hancock RE, Schneider G: Designing antimicrobial peptides: form follows function. Nature reviews Drug discovery 2012; 11:37-51.
Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW: Membrane pores induced by magainin. Biochemistry 1996; 35:13723-8.
Rapaport D, Shai Y: Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. Journal of Biological Chemistry 1991; 266:23769-75.
Gazit E, Miller IR, Biggin PC, Sansom MS, Shai Y: Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes. Journal of molecular biology 1996; 258:860-70.
Wimley WC, Hristova K: Antimicrobial peptides: successes, challenges and unanswered questions. The Journal of membrane biology 2011; 239:27-34.
Yeaman MR, Yount N:. Mechanisms of antimicrobial peptide action and resistance. Pharmacological reviews 2003; 55:27-55.
Hancock RE, Nijnik A, Philpott DJ: Modulating immunity as a therapy for bacterial infections. Nature Reviews Microbiology 2012; 10:243-54.
Steckbeck J, Deslouches B, Montelaro R: Antimicrobial peptides: new drugs for bad bugs? Expert Opinion on Biological Therapy 2013; 14:1114.
Chen Y, Xu X, Hong S, Chen J, Liu N, Underhill CB, Creswell K, Zhang L: RGD-Tachyplesin inhibits tumor growth. Cancer research 2001; 61:2434-8.
Butler MS, Cooper MA: Antibiotics in the clinical pipeline in 2011. The Journal of antibiotics 2011; 64:413-25.
Kang SJ, Park SJ, Mishig-Ochir T, Lee BJ: Antimicrobial peptides: therapeutic potentials. Expert review of anti-infective therapy 2014; 12:1477-86.
Ahmad M, Hirz M, Pichler H, Schwab H: Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Applied microbiology and biotechnology 2014; 98:5301-17.
Helmerhorst EJ, Reijnders IM, van't Hof W, Veerman EC, Nieuw Amerongen AV: A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides. FEBS letters 1999; 449:10510.
Hancock R: Cationic antimicrobial peptides: towards clinical applications. Expert Opinion on Investigational Drugs 2000; 9:1723-1729.
Mylne JS, Wang CK, van der Weerden NL, Craik DJ: Cyclotides are a component of the innate defense of Oldenlandia affinis. Peptide Science 2010; 94:635-46.
Tam JP, Lu YA, Yang JL: Correlations of cationic charges with salt sensitivity and microbial specificity of cystine-stabilized β -strand antimicrobial peptides. Journal of Biological Chemistry 2002; 277:504506.
Chan DI, Prenner EJ, Vogel HJ: Tryptophan-and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochimica et Biophysica Acta (BBA)-Biomembranes 2006; 1758:1184-202.
Li Y: Recombinant production of antimicrobial peptides in Escherichia coli: a review. Protein expression and purification 2011; 80:260-7.
Bahar AA, Ren D: Antimicrobial peptides. Pharmaceuticals 2013; 6(12):1543-75.
Jiang Z, Vasil AI, Hale JD, Hancock RE, Vasil ML, Hodges RS: Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α - helical cationic antimicrobial peptides. Peptide Science 2008; 90:369-83.
Pakkala M, Hekim C, Soininen P, Leinonen J, Koistinen H, Weisell J, Stenman UH, Vepsäläinen J, Närvänen A: Activity and stability of human kallikrein ‐ 2 ‐ specific linear and cyclic peptide inhibitors. Journal of Peptide Science 2007; 13:348-53.
Nguyen LT, Chau JK, Perry NA, De Boer L, Zaat SA, Vogel HJ: Serum stabilities of short tryptophan-and arginine-rich antimicrobial peptide analogs. PloS one 2010; 5:e12684.
Meng H, Kumar K: Antimicrobial activity and protease stability of peptides containing fluorinated amino acids. Journal of the American Chemical Society 2007; 129:15615-22.
Kim H, Jang JH, Kim SC, Cho JH: De novo generation of short antimicrobial peptides with enhanced stability and cell specificity. Journal of Antimicrobial Chemotherapy 2014; 69:121-32.
Zhang L, Benz R, Hancock RE: Influence of proline residues on the antibacterial and synergistic activities of α -helical peptides. Biochemistry 1999; 38:8102-11.
Strömstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M: Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrobial agents and chemotherapy 2009; 53593-602.
Nguyen LT, Schibli DJ, Vogel HJ: Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin. Journal of Peptide Science 2005; 11:379-89.
Kim JY, Park SC, Yoon MY, Hahm KS, Park Y: C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria. Amino Acids 2011; 40:183-95.
Malmsten M, Kasetty G, Pasupuleti M, Alenfall J, Schmidtchen A: Highly selective end-tagged antimicrobial peptides derived from PRELP. PloS one 2011; 6:e16400.
Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ: Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. International journal of antimicrobial agents 2008; 32:130-8.
Jureti ć D, Vuki č evi ć D, Petrov D, Novkovi ć M, Bojovi ć V, Lu č i ć B, Ili ć N, Tossi A: Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides. European biophysics journal 2011; 40:371-85.
Aoki W, Ueda M: Characterization of antimicrobial peptides toward the development of novel antibiotics. Pharmaceuticals 2013; 6:1055-81.
Su Y, Waring AJ, Ruchala P, Hong M: Structures of β -hairpin antimicrobial protegrin peptides in lipopolysaccharide membranes: mechanism of Gram selectivity obtained from solid-state nuclear magnetic resonance. Biochemistry 2011; 50:2072-83.
Svensäter G, Sjögreen B, Hamilton IR: Multiple stress responses in Streptococcus mutans and the induction of general and stress-specific proteins. Microbiology 2000; 146:107-17.
Aoki W, Kitahara N, Miura N, Morisaka H, Kuroda K, Ueda M: Design of a novel antimicrobial peptide activated by virulent proteases. Chemical biology & drug design 2012; 80:725-33.
Brandelli A: Nanostructures as promising tools for delivery of antimicrobial peptides. Mini reviews in medicinal chemistry 2012; 12:731-41.
Yount NY, Yeaman MR: Emerging themes and therapeutic prospects for anti-infective peptides. Annual review of pharmacology and toxicology 2012; 52:337-60.
de Azevedo J, Walter F, Dias R: Computational methods for calculation of ligand-binding affinity. Current drug targets 2008; 9:1031-9.
Robinson JA: Protein epitope mimetics as anti-infectives. Current opinion in chemical biology 2011; 15:379-86.
Matyus E, Kandt C, Tieleman DP: Computer simulation of antimicrobial peptides. Current medicinal chemistry 2007; 14:2789-98.
Jorgensen WL: Efficient drug lead discovery and optimization. Accounts of chemical research 2009; 42:724-33.
Engel T: Basic overview of chemoinformatics. Journal of chemical information and modeling. 2006; 46:2267-77.
Schneider G, Baringhaus KH: Molecular design: concepts and applications. (John Wiley & Sons) 2008.
Koch U, Hamacher M, Nussbaumer P: Cheminformatics at the interface of medicinal chemistry and proteomics. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 2014; 1844:156-61.
Da Costa JP, Cova M, Ferreira R, Vitorino R: Antimicrobial peptides: an alternative for innovative medicines? Applied microbiology and biotechnology 2015; 99:2023-40.
Marr AK, Gooderham WJ, Hancock RE: Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Current opinion in pharmacology 2006; 6:468-72.
Ramesh S, Govender T, Kruger HG, Torre BG, Albericio F: Short AntiMicrobial Peptides (SAMPs) as a class of extraordinary promising therapeutic agents. Journal of Peptide Science 2016; 22:438-51.
Hilpert K, Mikut R, Ruden S, Roland Berecz: Antimicrobial peptides for treatment of infectious diseases WO2013053772 A1.
Kang HK, Kim C, Seo CH, Park Y: The therapeutic applications of antimicrobial peptides (AMPs): a patent review. Journal of Microbiology 2017; 55:1-2.
Published
How to Cite
Issue
Section
Copyright (c) 2017 Imran safder, Amjad Islam
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at